Logo image of CSSE

CHICKEN SOUP FOR THE SOUL EN (CSSE) Stock Fundamental Analysis

NASDAQ:CSSE - Nasdaq - US16842Q1004 - Common Stock - Currency: USD

0.1055  -0.01 (-10.21%)

After market: 0.054 -0.05 (-48.82%)

Fundamental Rating

2

Overall CSSE gets a fundamental rating of 2 out of 10. We evaluated CSSE against 71 industry peers in the Entertainment industry. CSSE has a bad profitability rating. Also its financial health evaluation is rather negative. CSSE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CSSE had negative earnings in the past year.
In the past year CSSE has reported a negative cash flow from operations.
In the past 5 years CSSE always reported negative net income.
In the past 5 years CSSE always reported negative operating cash flow.
CSSE Yearly Net Income VS EBIT VS OCF VS FCFCSSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

CSSE has a worse Return On Assets (-152.35%) than 92.11% of its industry peers.
Industry RankSector Rank
ROA -152.35%
ROE N/A
ROIC N/A
ROA(3y)-62.52%
ROA(5y)-47.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSSE Yearly ROA, ROE, ROICCSSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CSSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSSE Yearly Profit, Operating, Gross MarginsCSSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

More info and screens

0

2. Health

2.1 Basic Checks

CSSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CSSE has more shares outstanding
CSSE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CSSE is higher compared to a year ago.
CSSE Yearly Shares OutstandingCSSE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CSSE Yearly Total Debt VS Total AssetsCSSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

CSSE has an Altman-Z score of -4.31. This is a bad value and indicates that CSSE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CSSE (-4.31) is worse than 81.58% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.31
ROIC/WACCN/A
WACC1.09%
CSSE Yearly LT Debt VS Equity VS FCFCSSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

2.3 Liquidity

A Current Ratio of 0.53 indicates that CSSE may have some problems paying its short term obligations.
The Current ratio of CSSE (0.53) is worse than 75.00% of its industry peers.
A Quick Ratio of 0.53 indicates that CSSE may have some problems paying its short term obligations.
CSSE's Quick ratio of 0.53 is on the low side compared to the rest of the industry. CSSE is outperformed by 72.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
CSSE Yearly Current Assets VS Current LiabilitesCSSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CSSE have decreased strongly by -151.68% in the last year.
Looking at the last year, CSSE shows a very negative growth in Revenue. The Revenue has decreased by -36.32% in the last year.
CSSE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.38% yearly.
EPS 1Y (TTM)-151.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
Revenue 1Y (TTM)-36.32%
Revenue growth 3Y64.28%
Revenue growth 5Y61.38%
Sales Q2Q%-75%

3.2 Future

The Earnings Per Share is expected to grow by 23.89% on average over the next years. This is a very strong growth
Based on estimates for the next years, CSSE will show a quite strong growth in Revenue. The Revenue will grow by 10.04% on average per year.
EPS Next Y42.18%
EPS Next 2Y62.8%
EPS Next 3Y39.86%
EPS Next 5Y23.89%
Revenue Next Year21.93%
Revenue Next 2Y18.06%
Revenue Next 3Y13.53%
Revenue Next 5Y10.04%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CSSE Yearly Revenue VS EstimatesCSSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CSSE Yearly EPS VS EstimatesCSSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CSSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 0.03 indicates a rather cheap valuation of CSSE.
100.00% of the companies in the same industry are more expensive than CSSE, based on the Price/Forward Earnings ratio.
CSSE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 0.03
CSSE Price Earnings VS Forward Price EarningsCSSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSSE Per share dataCSSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

CSSE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSSE's earnings are expected to grow with 39.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.8%
EPS Next 3Y39.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CSSE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHICKEN SOUP FOR THE SOUL EN

NASDAQ:CSSE (7/2/2024, 8:13:23 PM)

After market: 0.054 -0.05 (-48.82%)

0.1055

-0.01 (-10.21%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-13 2024-05-13/amc
Earnings (Next)08-12 2024-08-12/amc
Inst Owners0.05%
Inst Owner Change6123.65%
Ins Owners3.12%
Ins Owner Change0%
Market Cap3.42M
Analysts43.33
Price Target2.81 (2563.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.51
Dividend Growth(5Y)-0.36%
DP-1.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-72.95%
Min Revenue beat(2)-76.17%
Max Revenue beat(2)-69.74%
Revenue beat(4)0
Avg Revenue beat(4)-54.39%
Min Revenue beat(4)-76.17%
Max Revenue beat(4)-34.76%
Revenue beat(8)2
Avg Revenue beat(8)-23.46%
Revenue beat(12)2
Avg Revenue beat(12)-17.11%
Revenue beat(16)5
Avg Revenue beat(16)-11.51%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.03
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.06
EYN/A
EPS(NY)3.96
Fwd EY3751.28%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS6.54
BVpS-17.12
TBVpS-24.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -152.35%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-62.52%
ROA(5y)-47.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.79%
Cap/Sales 3.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -4.31
F-Score2
WACC1.09%
ROIC/WACCN/A
Cap/Depr(3y)4.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-151.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
EPS Next Y42.18%
EPS Next 2Y62.8%
EPS Next 3Y39.86%
EPS Next 5Y23.89%
Revenue 1Y (TTM)-36.32%
Revenue growth 3Y64.28%
Revenue growth 5Y61.38%
Sales Q2Q%-75%
Revenue Next Year21.93%
Revenue Next 2Y18.06%
Revenue Next 3Y13.53%
Revenue Next 5Y10.04%
EBIT growth 1Y-31.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year224.06%
EBIT Next 3Y56.56%
EBIT Next 5Y32.71%
FCF growth 1Y60.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.99%
OCF growth 3YN/A
OCF growth 5YN/A